ASH2022注目テーマ①「Late-Breaking Abstracts Session #1」

MRD陰性となったB-ALLの地固め療法で
ブリナツモマブの併用によりOSが延長 Consolidation Therapy with Blinatumomab Improves Overall Survival in Newly Diagnosed Adult Patients with B-Lineage Acute Lymphoblastic Leukemia in Measurable Residual Disease Negative Remission: Results from the ECOG-ACRIN E1910 Randomized Phase Ⅲ National Cooperative Clinical Trials Network Trial (#LBA-1)

Mark R. Litzow（Division of Hematology, Mayo Clinic, Rochester, MN, USA）